FMR CORP 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 10,809,235 15.000% |
1,449,145 (+15.48%) |
Filing |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 9,360,090 15.004% |
3,313,881 (+54.81%) |
Filing |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 6,046,209 12.253% |
2,099,889 (+53.21%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 3,946,320 8.012% |
568,300 (+16.82%) |
Filing |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 3,378,020 6.926% |
3,378,020 (New Position) |
Filing |